

































































Electrochemical microfluidic immunosensor based on TES-AuNPs@Fe3O4 and 1 
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We report a microfluidic immunosensor for the electrochemical determination of 26 
IgG antibodies anti-Toxocara canis (IgG anti-T. canis). In order to improve the selectivity 27 
and sensitivity of the sensor, core-shell gold-ferric oxide nanoparticles (AuNPs@Fe3O4), 28 
and ordered mesoporous carbon (CMK-8) in chitosan (CH) were used. IgG anti-T. canis 29 
antibodies detection was carried out using a non-competitive immunoassay, in which 30 
excretory secretory antigens from T. canis second-stage larvae (TES) were covalently 31 
immobilized on AuNPs@Fe3O4. CMK-8-CH and AuNPs@Fe3O4 were characterized by 32 
transmission electron microscopy, scanning electron microscopy, energy dispersive 33 
spectrometry, cyclic voltammetry, electrochemical impedance spectroscopy, and N2 34 
adsorption-desorption isotherms. 35 
Antibodies present in serum samples immunologically reacted with TES, and then 36 
were quantified by using a second antibody labeled with horseradish peroxidase (HRP-anti-37 
IgG). HRP catalyzes the reduction from H2O2 to H2O with the subsequent oxidation of 38 
catechol (H2Q) to p-benzoquinone (Q). The enzymatic product was detected 39 
electrochemically at 
_
100 mV on a modified sputtered gold electrode. The detection limit 40 
was 0.10 ng mL
-1
, and the coefficients of intra- and inter-assay variation were less than 6 41 
%, with a total assay time of 20 min. As can be seen, the electrochemical immunosensor is 42 
a useful tool for in situ IgG antibodies anti-T. canis determination. 43 
 44 
 45 




































































1. Introduction 49 
Toxocariosis is a disease caused by Toxocara canis and less commonly by 50 
Toxocara cati, which are global prolific nematodes with a complex life cycle [1]. The 51 
infection in humans is acquired by oral route through accidental ingestion of infective eggs 52 
from soil-contaminated hands, consumption of poorly sanitized vegetables, and uncooked 53 
meats [2, 3]. Toxocara eggs hatch in the intestine and release larvae into the lumen, where 54 
they can penetrate the intestine, reach the circulation and then spread by the systemic route. 55 
The larvae migrate throughout the body but cannot mature, and instead encyst as second-56 
stage larvae [4]. The inflammatory process, caused by the larvae stage, is attributed to small 57 
amounts of secretion and excretion products (lectins, mucins, enzymes), which interact and 58 
modulate the host immune response [5]. In brief, clinical manifestations of toxocariosis are 59 
related to the larval migration and the host immune response. The clinical forms of 60 
toxocariosis are systemic (visceral larva migrans), localized (ocular and neurological), and 61 
asymptomatic [6]. 62 
Human toxocariosis is diagnosed by clinical manifestations, ophthalmology (OLM), 63 
clinical pathology, including eosinophilia, bioimaging, and serology. In cases of OLM, 64 
extirpation by biopsy and subsequent histopathology can be performed and parasite 65 
material can be speciated by PCR. Moreover, serological methods using immunological 66 
techniques are recognized as the most effective approach to the laboratory diagnosis of 67 
human toxocariosis [7]. In this context, detection of IgG antibodies to T. canis by methods 68 
as enzyme-linked immunosorbent assay (ELISA) using excretory-secretory antigens from 69 
T. canis second stage larvae (TES) is the most widely used [8, 9]. 70 
In recent years, immunosensors promise to be the solution to the immunodiagnostic 71 


































































electrochemical detection represent an attractive strategy due to their advantages, such as 73 
the high degree of integration, low consumption of reagents and samples, and low detection 74 
limit [16-18]. These devices are considered to be valuable and promising due to their 75 
robustness, simplicity, sensitivity, ease of handling, cost-effectiveness, rapid analysis and 76 
miniaturization ability [19, 20]. Furthermore, microfluidic immunosensors modified with 77 
nanoparticles possess higher selectivity than naked sensors, and have higher sensitivity 78 
because of the increased surface area provided by the nanoparticles [21-24]. Recently, the 79 
synthesis of magnetic nanoparticles increased, and they were applied in numerous scientific 80 
fields such as proteins purification, biological separations, target delivery, magnetic 81 
resonance imaging, therapy, and biosensors fabrication [25-27]. In addition, much interest 82 
has been deposited in the incorporation of magnetic nanomaterials to other functional 83 
platforms or nanostructures. The exceptional applicability properties are the advantages of 84 
the new structures [28]. Among these, the iron-gold core-shell structure has drawn attention 85 
due to the apparent benefits of gold nanoparticles (AuNPs). Gold is an inert element, very 86 
useful as a coating material for protecting magnetic nanoparticles, due to the high 87 
versatility in surface modification processes, great catalytic properties, and unique 88 
biocompatibility [29, 30]. Up till now, gold-ferric oxide core/shell nanoparticles 89 
(AuNPs@Fe3O4) have been considered as excellent candidates to be used as biomolecules 90 
immobilization platform, for capture and recognition elements (antigens, antibodies, 91 
enzymes or DNA) in microfluidic immunosensors, because of their simple synthesis, 92 
excellent biocompatibility and large surface area [31]. 93 
Another strategy to be employed in the microfluidic immunosensor design is the 94 
modification of the working electrode surface with different materials, such as ordered 95 


































































modification because of their excellent electrical conductivity, high surface area, chemical 97 
and thermal stability, and their facile functionalization [33-36]. 98 
In the present work, we developed an electrochemical microfluidic immunosensor 99 
for the toxocariosis diagnosis based on the use of core-shell AuNPs@Fe3O4 for covalent 100 
immobilization of TES antigen, and the working electrode modification with CMK-8 in 101 
chitosan (CH). IgG anti-T. canis antibodies present in the serum samples were detected by 102 
using a non-competitive immunoassay into the microfluidic device. To the best of our 103 
knowledge, this is the first electrochemical microfluidic immunosensor reported for the IgG 104 
anti-T. canis antibodies detection based on magnetic core-shell nanoparticles and ordered 105 
mesoporous carbon materials. 106 
 107 
2. Experimental 108 
2.1. Materials and reagents 109 
All reagents used were of analytical reagent grade. Triblock copolymer P123, 110 
tetraethyl orthosilicate (TEOS 98%), CH (from crab shells, medium molecular, 85% 111 
deacetylated), FeCl2, FeCl3, [Fe(CN)6]
3-/4-
, HAuCl4, 3-mercaptopropionic acid (MPA), 112 
Bovine serum albumin (BSA), 4-tert-butylcatechol (4-TBC) N-(3-dimethylaminopropyl)-113 
N-ethylcarbodiimide (ECD), and N-hydroxysuccinimide (NHS) were acquired from Sigma-114 
Aldrich, St. Louis, USA. Disodium phosphate (Na2HPO4), monosodium phosphate 115 
(NaH2PO4), trisodium citrate dehydrate, potassium chloride (KCl), and ethanol were 116 
purchased from Merck (Darmstadt, Germany). SU-8 photoresist, Sylgard 184, including 117 
PDMS prepolymer and curing agent were obtained from Clariant Corporation 118 
(Sommerville, NJ, USA) and Dow Corning (Midland, MI, USA), respectively. The enzyme 119 


































































human serum (RIDASCREEN® Toxocara IgG test) was purchased from R-Biopharm AG 121 
(Darmstadt, Germany), and used according to the manufacturer's instructions. Anti-human 122 
γ-chain was purchased from Abcam (USA). All the other employed reagents were of 123 
analytical grade and were used without further purification. Aqueous solutions were 124 
prepared by using purified water from a Milli-Q system. 125 
 126 
2.2. Apparatus 127 
Amperometric and voltammetric experiments were performed with a BAS LC-4C 128 
Electrochemical Detector, and a BAS 100 B/W Electrochemical Workstation (Bioanalytical 129 
Systems, Inc. West Lafayette, IN, USA), respectively. Electrochemical measurements were 130 
carried out using a microfabricated electrochemical cell with three electrodes (gold working 131 
and counter electrodes, and silver reference electrode). All the potentials were referred to 132 
Ag. EIS measurements were performed using a PGSTAT128N potentiostat from Methrohm 133 
Autolab, with a NOVA 1.11 electrochemical analysis software. 134 
Scanning electron microscope images were taken on a LEO 1450VP instrument 135 
(UK), equipped with an Energy Dispersive Spectrometer analyzer, Genesis 2000 (England). 136 
Sputtering deposition was made with a SPI-Module Sputter Coater (Structure Probe Inc, 137 
West Chester, PA). The electrode thickness was controlled using a Quartz Crystal 138 
Thickness Monitor model 12161 (SPI-Module, Structure Probe Inc, West Chester, PA). 139 
A syringe pumps system (Baby Bee Syringe Pump, Bioanalytical Systems, Inc. 140 
West Lafayette, IN, USA) was used for introducing the solutions in the device. All 141 
solutions employed were injected using syringe pumps at flow rate of 2 μL min
-1
. All 142 
solutions and reagent temperatures were conditioned before the experiment using a Vicking 143 


































































detected by Bio-Rad Benchmark microplate reader (Japan) and Beckman DU 520 general 145 
UV/VIS spectrophotometer. All pH measurements were made with an Orion Expandable 146 
Ion Analyzer (Orion Research Inc., Cambridge, MA, USA) Model EA 940 equipped with a 147 
glass combination electrode (Orion Research Inc). 148 
 149 
2.3. Fabrication of the microfluidic device 150 
The microfluidic device manufacture involved four steps: i) Deposition of Ag/Au 151 
electrodes by sputtering on a glass plate, ii) Fabrication of the PMDS molds by 152 
photolithography, iii) CMK-8-CH deposition on the Au working electrode (GE), and iv) 153 
Sealing of the glass/PDMS. The fabrication of the microfluidic electrochemical 154 
immunosensor was carried out according to the procedure previously reported with the 155 
following modifications [18] (Scheme 1): For the construction of the electrode, a self-156 
adhesive vinyl sheet patterned mask was employed. The mask was positioned at the end of 157 
the central channel (CC), followed by sputtering deposition of 100 nm silver and 100 nm 158 
gold over a glass plate. The vinyl mask was removed after sputtering, leaving the gold and 159 
silver tracks on the glass. The geometric area was 1.0 mm
2
 for the working electrode, and 160 
2.0 mm
2
 for the counter and reference electrodes. 161 
PDMS microchannels were cast by photolithography. The channels design in the 162 
negative mask was generated by a computer program. The replication master was patterned 163 
with a SU-8 photoresist layer over a silicon wafer using a spin coater at 2200 rpm for 30 s, 164 
and baked at 60 °C for 2 min and 90 °C for 5 min. Then, the coated sheet was exposed to a 165 
UV lamp through a negative mask with the T-configuration design (two inlets for reagents 166 
and buffer, respectively and one outlet) with 200-μm-width and 100-μm-hight, with a 167 


































































unexposed photoresist was removed. Then, the Sylgard curing agent was mixed with 169 
PDMS prepolymer (1:10), and placed on the replication master (degassed for 30 min to 170 
eliminate air bubbles). The polymer curing process was carried out in a hot plate at 70 °C 171 
for 45 h. The PDMS was then peeling off, and the external access to the microfluidic device 172 
was obtained by drilling holes. After that, the glass plate and PDMS were placed in oxygen 173 
plasma for 1 min and were contacted immediately for a strong seal. 174 
 175 
2.4. Synthesis of CMK-8 176 
As mentioned before, CMK-8 was prepared using KIT-6 as a hard template. KIT-6 177 
was synthetized according to a procedure previously reported with slight modifications 178 
[37]. Firstly, 9.6g:346.6g:18.8g of P123, double distilled water and HCl, respectively, were 179 
mixed. After P123 dissolution, 9.6 g of butanol were added, and the solution was stirred for 180 
1 h at 35 °C, followed by addition of 24.8 g TEOS with continuous stirring at 35 °C for 12 181 
h. Then, the temperature was raised at 120 °C for 24 h. The white precipitate was washed 182 
by double distilled water several times, and dried at 120 °C. KIT-6 was obtained after 183 
calcination at 550 °C for 3 h. 184 
CMK-8 was synthesized following the procedure with some modifications [36]. 185 
Sucrose was used as a carbon source. Firstly, 0.5g:0.6g:0.1g:5mL KIT-6, sucrose, H2SO4 186 
and H2O were mixed and stirred for 15 min. Then, the suspension was dried at 100 °C for 6 187 
h, followed by increasing the temperature at 160 °C for another 6 h. After that, a second 188 
impregnation step was carried out to ensure the KIT-6 pores filling by adding 189 
2mL:0.4g:0.05g H2O, sucrose and H2SO4, followed by the temperature treatment. The dark 190 
brown mixture was carbonized at 900 °C in N2 for 6 h to achieve complete carbonization. 191 
Lastly, the powder was washed several times with 2 mol L
-1


































































inorganic silica template. The black solid was filtered and washed with ethanol:NaOH 193 
(50:50 % v/v), and finally dried at 120 °C for 12 h. 194 
In order to improve the hydrophilicity of mesoporous carbon for the electrochemical 195 
use in sensors, CMK-8 was treated with 70 % HNO3 at 60 °C for 1 h and subsequently 196 
washed with double distilled water until neutral pH [34]. CMK-8 was characterized by 197 
transmission electron microscopy (TEM), and N2 adsorption-desorption isotherms. 198 
 199 
2.5. CMK-8-CH/GE preparation 200 
A chitosan solution was prepared by adding 1 g of CH in 100 mL of an ethanol:H2O 201 
(1:4) mixture at pH 3.00 with HCl addition under stirring conditions. The undissolved 202 
material was filtered. Then, the pH value was gradually increased to 8.00 with NaOH. 1 % 203 
CH solution was stored at 4 ºC until use [38]. 204 
After that, 0.9 mg of CMK-8 was dispersed in 1 mL of 1 % CH with the ultrasonic 205 
stirring aid for 1 h. The CMK-8-CH suspension was stable for at least 2 months at 4 ºC. 206 
Finally, 10 µL of the obtained CMK-8-CH were dropped on the GE, and the solvent was 207 
evaporated under an infrared heat lamp. CMK-8-CH/GE was characterized by scanning 208 
electron microscopy (SEM), energy dispersive spectrometry (EDS), cyclic voltammetry 209 
(CV), and electrochemical impedance spectroscopy (EIS). 210 
 211 
2.6. Synthesis of core-shell AuNPs@Fe3O4 212 
Firstly, Fe3O4 nanoparticles were prepared by co-precipitation method following the 213 
procedure previously published by Salihov et al. with some modifications [29]. Briefly, a 214 
100 mL 0.1 mol L
-1
 FeCl2·and 0.2 mol L
-1
 FeCl3 solution was prepared with 0.1 mol L
-1
 215 
HCl. Then, 1 mol L
-1


































































min under N2 atmosphere. The black suspension obtained was separated using a 217 
neodymium magnet, and washed several times using N2 purged double distilled water. The 218 
Fe3O4 nanoparticles suspension was dried in vacuum oven and kept at 4 °C for further use. 219 
After that, Fe3O4 nanoparticles were resuspended in double distilled water, and the 220 
suspension was ultrasonicated for 15 min. Then, 1 mL of 0.1 mol L
-1
 HAuCl4 solution was 221 
added to the suspension in stirring condition at 75 °C. Finally, 5 mL of 0.1 mol L
-1
 222 
trisodium citrate dehydrate solution were added to the mixture [39]. The solution was 223 
stirred at 75 °C for 45 min until a reddish color suspension. AuNPs@Fe3O4 nanoparticles 224 
were washed several times using N2 purged double distilled water using a neodymium 225 
magnet. The suspension was dried in vacuum oven and kept at 4 °C for further use. 226 
AuNPs@Fe3O4 was characterized by SEM and EDS. 227 
 228 
2.7. T. canis second-stage larvae (TES) antigen preparation 229 
TES antigens were obtained according to the technique described by Gillespie [13]. 230 
TES were maintained at 35 °C with 5 % CO2 atmosphere and adjusted to pH 6.5 in Iscove's 231 
modified Dulbecco's culture medium supplemented with HEPES buffer and a Penicillin-232 
Streptomycin solution. The culture supernatant was removed weekly, and the supernatant 233 
pool was kept at -70 °C. The supernatant pool was concentrated by filtration through 234 
polyethersulphone membranes and dialysed. The protein content was then estimated by the 235 
Bradford method with bovine albumin as the standard protein. 236 
 237 
2.8. TES immobilization on AuNPs@Fe3O4 238 
10 mg of AuNPs@Fe3O4 were resuspended with MPA 50 mmol L
-1
 in an 239 


































































Au surface, giving, as a result, free carboxylic groups, which are activated by rinsing with 241 
an EDC:NHS solution in 10 mmol L
-1
 phosphate buffer saline (PBS) for 2 h at pH 7.00. 242 
Then, the AuNPs@Fe3O4 nanoparticles were washed several times using a neodymium 243 
magnet and dried with N2. 244 
After that, the AuNPs@Fe3O4 were put in contact with 1 mL of 100 μg mL
-1
 TES 245 
solution in 10 mmol L
-1
 PBS pH 7.00 for 10 h at 4 ºC. Finally, the nanoparticles were 246 
rinsed with 10 mmol L
-1
 PBS pH 7.00 and stored in the same buffer at 4 ºC when not in 247 
use. The immobilized antigen preparation was perfectly stable for at least 1 month. Scheme 248 
2 shows the procedure for TES-AuNPs@Fe3O4 preparation. 249 
 250 
2.9. Analytical procedure for anti-T. canis IgG antibodies determination 251 
In this work, six serum samples obtained from patients with toxocariasis were 252 
analyzed. These samples showed a marked reactivity against T. canis. The procedure for 253 
anti-T. canis IgG antibodies determination involves the following steps. Firstly, TES-254 
AuNPs@Fe3O4 was introduced into the microfluidic channel and kept in the central 255 
channel using an external neodymium magnet. To avoid the unspecific bindings, a blocking 256 
treatment was carried out through with 1 % of bovine serum albumin (BSA) in 10 mmol L
-1
 257 
PBS pH 7.00 for 5 min, followed by a washing step with 10 mmol L
-1
 PBS pH 7.00 for 2 258 
min. 259 
Then, the serum samples (previously diluted 50-fold with 10 mmol L
-1
 PBS pH 260 
7.00), were injected for 5 min, followed by the washing step to remove the excess of the 261 
sample. In this step, the IgG specific antibodies to T. canis present in the samples react with 262 
TES immobilized on AuNPs@Fe3O4 surface. Later, IgG anti-T. canis were quantified by 263 


































































catalyzes the reduction of H2O2 to H2O, with the subsequent oxidation of catechol (H2Q) to 265 
p-benzoquinone (Q). Finally, the substrate solution (1 mmol L
-1
 H2O2 + 1 mmol L
-1
 4-TBC 266 
in 10 mmol L
-1
 phosphate-citrate buffer pH 5.00) was pumped, and the enzymatic product 267 
was detected by amperometry at -100 mV in the CMK-8-CH/GE (Scheme 2). 268 
Before each sample analysis, the immunosensor was exposed to a desorption buffer 269 
(0.1 mol L
-1
 citrate-HCl pH 2.00) for 5 min and then washed with 10 mmol L
-1
 PBS pH 270 
7.00. This procedure desorbed the anti-T. canis antibodies bound to immobilized TES, 271 
allowing to performed a new determination. The device can be used without significant loss 272 
of sensitivity for 1 month (decrease of 10 %). The microfluidic immunosensor was stored 273 
in 10 mmol L
-1
 PBS pH 7.00 at 4 ºC. 274 
 275 
3. Results and discussion 276 
3.1. CMK-8-CH/Au and AuNPs@Fe3O4 characterization 277 
CMK-8 specific surface area (SBET) was calculated according to the Brunauer-278 
Emmet-Teller method, using the adsorption data at relative pressures. Total pore volume 279 
(VTP) was found by the Gurvich’s rule. CMK-8 pore size distribution (PSD) was 280 
determined by VBS macroscopic method using the adsorption branch data [38]. Figure 1 a) 281 
shows a TEM image of CMK-8. The micrograph reveals a uniform long-range ordered 282 
mesoporous cubic pore structure with a 10 nm pore size approximately. Also, a study on 283 
the N2 adsorption-desorption isotherm at 77 K was carried out, and a type IV isotherm with 284 
an H2 hysteresis loop characteristic of mesoporous materials can be clearly seen (Figure 1 285 









. Figure 1 b) (inset), confirming that CMK-8 has a narrow pore size 287 


































































Morphology of the CMK-8-CH/GE nanocomposite film was analyzed by SEM. 289 
Figure 1 c) reveals a uniform CMK-8-CH film over the gold electrode surface. The 290 
nanocomposite three-dimensional structure film provides a suitable surface for a conductive 291 
pathway for electron-transfer. The nanocomposite elemental composition was determined 292 




 couple is an appropriate tool to study the electrode surface 295 
properties during several modification steps. Accordingly, Figure 2 a) shows CVs recorded 296 
with a bare GE and the CMK-8-CH/GE. Well-defined CVs characteristics of a diff usion-297 
controlled redox process were perceived at the bare GE, whereas enlarged peaks were 298 
noticed with the electrode modified with CMK-8-CH. The higher faradaic response 299 
observed with the CMK-8-CH/GE can be attributed to the increased electroactive surface 300 
area, and the excellent electrical conductivity of CMK-8. Another factor to take account is 301 
the hydrophilic surface obtained due to the synergic effect between CMK-8 and chitosan, 302 
which allow to improve the solution/electrode contact. 303 





in 0.1 mol L
-1
 KCl, applying a +150 mV potential and varying the frequency with 305 
logarithmic spacing frequency in the range from 0.1 Hz to 100 kHz. EIS data were 306 
represented in Nyquist plots (Fig. 2 b)), where the impedance spectrums includes a 307 
semicircle at higher frequencies that represents the electron transfer resistance (evidencing 308 
the blocking behavior of the bare/modified electrode surface towards the redox couple), and 309 
a linear part at lower frequencies that represents the diffusion process. The analytical signal 310 
considered is the Rct, evaluated by the iterative fitting of the experimental data to the 311 


































































is the Warburg impedance, and CPE is the constant phase element. As can be observed, the 313 
bare GE displays a lower electron transfer resistance (69 Ω), and the semicircle increased 314 
(Rct= 143 Ω) for the CH/GE due to the presence of an insulating layer formed as a 315 
consequence of the CH polymer deposition process. Such partial blockage of the electron 316 
transfer is then alleviated for the CMK-8-CH/GE, because of the excellent electrical 317 
conductivity of CMK-8, hence a decrease in the semicircle curve (Rct= 19 Ω) was noticed. 318 
As shown in Figure 2 c), a linear relationship between redox peak current and the 319 
square root of the scan rate is established in the 25 to 200 mV s
-1
range, indicating the 320 
electron-transfer process is diffusion controlled for the CMK-8-CH/GE. The apparent 321 
electroactive surface area of this modified electrode can be calculated by the Randles-322 
Sevcik equation and the value was found to be 0.195 cm
2
. 323 
Regarding the AuNPs@Fe3O4 nanoparticles characterization, Figure 3 a) shows the 324 
SEM images, and the nanoparticles diameters ranged from 10 to 50 nm. The nanoparticles 325 
elemental composition was determined by EDS and the O, Fe, and Au typical peaks can be 326 
clearly seen (Figure 3 b)). 327 
 328 
3.2. Optimization of experimental parameters 329 
Experimental parameters that affect the IgG anti-T. canis quantitation in biological 330 
samples were studied. For this purpose, an anti-T. canis IgG standard solution of 40 ng mL
-331 
1
 was employed. 332 
Firstly, the optimal flow rate for samples and reagents was analyzed employing 333 
several flow rates and evaluating the generated current during the immune reaction. As 334 
shown in Figure 4 a), flow rates varied from 1 to 2.5 μL min
-1
, showing an increase in the 335 
current response with the flow rate until 2.5 μL min
-1


































































due to the high flow reduced the interaction time between the immune reagents. Therefore, 337 
a flow rate of 2 μL min
-1
 was used for reagents, samples, and washing solutions. 338 
The influence of pH on the enzymatic response under flow conditions was also 339 
examined in the range from 4.00 to 6.50 (Figure 4 b). A current increase until pH 5.00 can 340 
be observed followed by a decrease at higher pH values up to pH 6.50. So, the pH 5.00 was 341 
selected as optimum in 10 mmol L
-1
 phosphate-citrate buffer. 342 
CMK-8 concentration employed for the gold electrode surface modification was 343 
also optimized. This study was carried out in the 0.5 to 1.2 mg mL
-1
 range. A significant 344 
signal increase was observed from 0.5 to 0.9 mg mL
-1
. However, at higher concentrations, 345 
insignificant differences were obtained. Then, 0.9 mg mL
-1
 CMK-8 was employed for the 346 
modification step (Figure 4 c)). 347 
An important parameter to be optimized was the concentration of the T. canis 348 
second-stage larvae (TES) to be immobilized in the AuNPs@Fe3O4. Such study was 349 
performed from 10 to 125 μg mL
-1
 TES, and the current response increased until 100 μg 350 
mL
-1
 TES. No significant changes were observed for higher TES concentrations, hence 100 351 
μg mL
-1
 TES was employed as an optimum concentration for AuNPs@Fe3O4 352 
immobilization (Figure 4 d)). 353 
Other important parameters such as CH concentration, amount of AuNPs@Fe3O4 354 
nanoparticles, among others, were also optimized (Data not shown). 355 
 356 
3.4. Analytical performance of the microfluidic immunosensor 357 
The analytical performance of our immunosensor was studied by measuring the 358 
response towards varying concentrations of anti-T. canis IgG in the 0.1-100 ng mL
-1
 359 
concentration range. A linear relationship was observed between 0.33-75 ng mL
-1


































































calibration curve was obtained by plotting current (nA) versus anti-T. canis IgG 361 
concentration (ng mL
-1
). The calibration curve was defined by ΔI (nA) = 15.86 – 2.21 CT. 362 
canis with a correlation coefficient of 0.992, where ΔI is the difference between blank and 363 
sample current. The standard deviation (SD) for the calibration curve was 4.45. The 364 
coefficient of variation (CV) for the determination of 40 ng mL
-1
 anti-T. canis IgG was 365 
below 4.92% (n=5). These values demonstrate that our microfluidic electrochemical 366 
immunosensor can be used to anti-T. canis IgG quantification in unknown samples. The 367 
limit of detection (LD) and the limit of quantification (LQ) were calculated according the 368 
IUPAC recommendations. For the electrochemical detection procedure, the LD and LQ 369 
were 0.10 and 0.5 ng mL
-1
, respectively. 370 
The precision of the electrochemical assay was checked with six anti-T. canis IgG 371 
standard solutions. The within-assay precision was tested with five measurements on the 372 
same day. These analyses were repeated for three consecutive days in order to estimate 373 
between-assay precision. The assay showed excellent precision; the CV % within-assay 374 
values were below 5 %, and the between-assay values were below 6 % (Table 1). The total 375 
assay time for anti-T. canis IgG determination was 20 min, much less than the time 376 
generally used for the conventional ELISA. 377 
The electrochemical method was compared with the fluorescent immunosensor 378 
previously reported, where IgG anti-T. canis was quantified using 3-aminopropyl-379 
functionalized silica-nanoparticles (AP-SNs) and cadmium selenide zinc sulfide quantum 380 
dots (CdSe-ZnS QDs) [13]. The slope obtained was practically close to the unit, indicating 381 
a good correspondence between both methods. Compared with the fluorescent 382 
immunosensor, the electrochemical immunosensor showed an improved LD. The F-test 383 


































































In order to evaluate the analytical applicability of the electrochemical immunosensor, IgG 385 
anti-Toxocara canis quantification was carried out in six human serum samples with 386 
toxocariasis, under the conditions previously described. These samples were confirmed by 387 
fluorescent immunosensor and commercial ELISA. The samples analyzed revealed similar 388 
IgG anti-T. canis concentrations, as can be observed in Table 2. 389 
 390 
4. Conclusions 391 
The designed microfluidic electrochemical immunosensor for IgG anti-T. canis 392 
detection in human serum samples shows outstanding analytical parameters. Our analytical 393 
method is based on the covalently immobilization of T. canis second-stage larvae antigens 394 
on core-shell gold nanoparticles-ferric oxide (AuNPs@Fe3O4) retained by an external 395 
magnet in the microfluidic channel. IgG anti-T. canis antibodies detection was carried out 396 
using a non-competitive immunoassay. The enzyme electrochemical mediator was 397 
measured over the order mesoporous carbon-chitosan (CMK-8-CH) modified gold 398 
electrode. The synthesized CMK-8 showed high specific surface area, large pore volume, 399 
uniform mesostructure, good conductivity, and excellent electrochemical activity, that 400 
allowed us to greatly improve the surface area of the sensor and its analytical performance. 401 
The total assay time employed was shorter than the time reported for commercial 402 
ELISA frequently used. The microfluidic electrochemical immunosensor offered several 403 
attractive advantages like high stability, high selectivity, and sensitivity. In conclusion, the 404 
device could be well suitable for biomedical sensing and clinical applications for diagnosis 405 
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Figure captions 548 
Scheme 1. Microfluidic device fabrication by photolithography. 549 
Scheme 2. Analytical procedure for IgG anti-T. canis determination in human serum 550 
samples. 551 
Figure 1. a) TEM image of CMK-8, b) N2 adsorption-desorption isotherm at 77 K, and 552 
PSD (inset) of CMK-8, c) SEM micrograph of CMK-8-CH/GE, and d) EDS of CMK-8-553 
CH/GE. 554 




 in 0.1 mol L
-1
 555 
KCl solution with a bare GE (b), and a CMK-8-CH/GE (c). Curve (a) corresponds to the 556 
CV recorded in the 0.1 mol L
-1
 KCl supporting electrolyte solution with the bare GE (Scan 557 
rate = 75 mV s
-1




 in 0.1 mol L
-1
 KCl, at 150 558 
mV, varying the frequency with logarithmic spacing frequency in the range from 0.1 Hz to 559 
100 kHz with bare GE, CH/GE, and CMK-8-CH/GE, and c) Cyclic voltammograms 560 




 in 0.1 mol L
-1
 KCl solution with the CMK-8-561 
CH/GE at different scan rates (from a-h): 25, 50, 75 100, 125, 150, 175, 200 mV s
-1
. The 562 




Figure 3. a) SEM micrograph of AuNPs@Fe3O4, and b) EDS of AuNPs@Fe3O4. 565 
Figure 4. (a) Optimization of microfluidic device flow rate, (b) Optimization of pH 566 
enzymatic response, (c) Optimization of CMK-8 concentration employed for the electrode 567 
surface modification, and (d) Optimization of T. canis second-stage larvae (TES) antigens 568 
immobilization. 569 
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Figure 3 592 






































































Figure 4 596 
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Table 1. Within-assay precision and between-assay precision for the microfluidic 600 
electrochemical immunosensor. 601 
Samples
a
 Within-assay Between-assay 
Mean
b
 CV % Mean CV % 
1 1.05 3.9 1.06 4.1 
5 5.09 4.3 5.10 4.7 
10 9.89 3.8 10.28 5.1 
25 25.41 4.9 25.71 5.8 
50 49.91 3.1 50.91 5.5 
70 70.61 4.5 70.82 4.9 
a
 Human serum samples ng mL
-1
 IgG anti-T. canis antibody. 602 
b
 Mean of three determinations + S.D. 603 
 604 



































































Table 2. Comparison of IgG anti-T. canis antibody concentration in human serum samples 607 
by microfluidic electrochemical immunosensor, microfluidic fluorescent immunosensor 608 








1    1.05 + 0.01
d
   1.07 + 0.02   0.93 + 0.03 
5   4.95 + 0.06   4.91 + 0.06   5.13 + 0.05 
10 10.14 + 0.05 10.16 + 0.04   9.88 + 0.06 
25 25.19 + 0.08 24.79 + 0.09 25.23 + 0.08 
50 49.13 + 0.10 49.23 + 0.12 50.47 + 0.14 
70 70.53 + 0.15 69.41 + 0.17 69.33 + 0.18 
a
 Human serum samples ng mL
-1
 IgG anti-T. canis antibody. 610 
b
 Microfluidic electrochemical immunosensor. 611 
c
 Microfluidic fluorescent immunosensor. 612 
d
 Mean of three determinations + S.D. 613 
 614 
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